{"id":"W1965195516","doi":"10.1016/j.clcc.2011.06.004","title":"The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status","year":2011,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"ca_institutions":"Amgen (Canada)","funders":"Amgen","keywords":"Panitumumab; Medicine; Irinotecan; FOLFIRI; Colorectal cancer; Oncology; Internal medicine; Toxicity; Cetuximab; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005904317,0.001081268,0.002297513,0.0008922155,0.0004181387,0.001273363,0.0008135177,0.0009454195,0.002859419],"category_scores_gemma":[0.004704926,0.0005855776,0.004954018,0.0008409583,0.0008217933,0.001088422,0.0005563386,0.002615812,0.0004331079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001385214,"about_ca_system_score_gemma":0.001350836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001428838,"about_ca_topic_score_gemma":0.002872495,"domain_scores_codex":[0.9964448,0.002152198,0.0002774559,0.0003601306,0.0004011182,0.0003643489],"domain_scores_gemma":[0.9958004,0.001761205,0.001196462,0.0005091527,0.0002648315,0.0004679329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9222233,0.002501234,0.03789161,0.000461873,0.008311728,0.0001058456,0.0000712679,0.002133993,0.005995835,0.0001034777,0.001011942,0.01918774],"study_design_scores_gemma":[0.2454342,0.250499,0.4513243,0.0001114255,0.02282203,0.0008195118,0.000156464,0.007573368,0.01643189,0.0007792136,0.003910534,0.0001381209],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942992,0.001448641,0.0004560162,0.00009035909,0.00004871979,0.0003775753,0.002144204,0.00003056335,0.0011048],"genre_scores_gemma":[0.9965204,0.0002570892,0.0002605067,0.00009699423,0.00005591166,0.0002637115,0.001835957,0.00001590746,0.0006934887],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005904317,"threshold_uncertainty_score":0.03122538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0947725036192167,"score_gpt":0.4069263352868261,"score_spread":0.3121538316676094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}